Priya Chockalingam

Priya Chockalingam

Company: Biogen

Job title: Director & Diagnostics Pathways Lead


Priya has a PhD in Biochemistry with nearly 20 years of pharmaceutical drug discovery & development experience from target id through first-in-human, clinical trials, approval & post-marketing.

Priya led translational biology efforts for the Musculoskeletal /Tissue Repair organization of legacy Wyeth, and the Inflammation & Immunology research unit of Pfizer from 2002-14. She was then Director & Group Lead for Translational, Biomarker & Diagnostic strategy, development & implementation through submission, approval & post-marketing for several rare disease clinical development programs at Shire/Takeda from 2014-19. She is currently the Diagnostics Pathways lead for Neuromuscular indications at Biogen.


Development & Implementation of Diagnostics for Rare Diseases 2:15 pm

Novel diagnostic approaches for rare diseases Rapid diagnostics at Point of Care for diagnosis and disease management Role of diagnostics in rare genetic diseasesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.